Overview

A Study Of PF-03882845 Absorption In Healthy Volunteers Given Orally As Tablet Versus Suspension Formulations And Effect Of Food On Its Absorption

Status:
Completed
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to estimate the relative bioavailability and food effect of a PF-03882845 tablet as compared to a suspension formulation used in previous clinical studies.
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer